Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER_GOV × Blood Specimen Collection × Clear all

Phase

Phase NA 6 Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 4 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

toripalimab 1 lenvatinib 1 fludarabine 1 epigallocatechin gallate 1 avelumab 1 Zinc 1 Tissue Banks 1 Quercetin 1 Pemetrexed 1 Paclitaxel 1 Metformin 1 Interleukin-2 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Blood Specimen Collection 1 Biopsy, Needle 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01302002 2016-02-23

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Instituto Nacional de Cancer, Brazil

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡